跳至主要内容
临床试验/NCT05671562
NCT05671562
已完成
不适用

A Randomised Placebo-controlled Trial to Investigate the Effect of Lactolycopene on Sperm Quality in Men With a Low Total Motile Sperm Count: a Pilot Study.

Sheffield Teaching Hospitals NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 34 人2023年5月3日

概览

阶段
不适用
干预措施
Lycopene
疾病 / 适应症
Total Motile Sperm Count
发起方
Sheffield Teaching Hospitals NHS Foundation Trust
入组人数
34
试验地点
1
主要终点
Total motile sperm count
状态
已完成
最后更新
2个月前

概览

简要总结

The goal of this clinical trial is to test whether lycopene (an antioxidant found in cooked tomatoes) will improve the number of swimming sperm in the ejaculates of men with low total motile sperm count.

Participants will take either lycopene capsules or identical capsules containing no lycopene for 12 weeks. We will analyse the quality of their semen before and after taking the capsules, and compare the results.

Hypothesis: Supplementation with lycopene will improve testicular function (semen quality) in males with low total motile sperm count (TMSC).

详细描述

Impaired testicular function contributes to around 50% of heterosexual infertility and is often characterized by a low total motile sperm count. Evidence suggests that one cause of low total motile sperm count is oxidative stress within the ejaculate, where harmful oxygen species damage the sperm. Antioxidants to combat oxidative stress within the ejaculate have been proposed as a method of increasing the total motile sperm count. Lycopene is a powerful antioxidant found abundantly in cooked tomatoes and has been shown to improve testicular function in a healthy population. This double blinded randomised controlled trial aims to investigate whether lycopene can improve testicular output in participants with a low motile sperm count. Semen analysis will be carried out before and after the intervention. The intervention is a commercially available lycopene capsule or an identical placebo. Hypothesis: Supplementation with lactolycopene will improve testicular function (semen quality) in males with low total motile sperm count (TMSC).

注册库
clinicaltrials.gov
开始日期
2023年5月3日
结束日期
2025年12月31日
最后更新
2个月前
研究类型
Interventional
研究设计
Parallel
性别
Male

研究者

入排标准

入选标准

  • Males aged 18 - 50 years of age
  • Attending the Fertility Clinic at the Jessop Wing, (Sheffield Teaching Hospitals).
  • Found to have poor testicular function as evidenced by a low motile sperm count (\<20 million motile sperm per ejaculate).
  • Willing to comply with the study procedures and provide informed consent.

排除标准

  • Participants who report allergy to tomatoes, whey, soy.
  • Men with previous testicular surgery or a current or previous diagnosis of cancer.
  • Men found to have normal sperm parameters.
  • Known infection with hepatitis or HIV.
  • Men with azoospermia

研究组 & 干预措施

Lycopene

Capsules containing 7mg of lycopene. 2 capsules are swallowed once per day with water for 12 weeks. Looks identical to placebo capsule.

干预措施: Lycopene

Placebo

Placebo capsules containing an inactive ingredient. 2 capsules are swallowed once per day with water for 12 weeks. Looks identical to lycopene capsule.

干预措施: Placebo

结局指标

主要结局

Total motile sperm count

时间窗: Change from Baseline total motile sperm count at 12 weeks

Number of swimming sperm in the total ejaculate

次要结局

  • Sperm motility(Change from Baseline sperm motility at 12 weeks)
  • Sperm DNA fragmentation(Change from Baseline sperm DNA fragmentation at 12 weeks)
  • Sperm concentration(Change from Baseline sperm concentration at 12 weeks)
  • Sperm morphology(Change from Baseline sperm morphology at 12 weeks)
  • Oxidative reductive potential of semen(Change from Baseline semen oxidative reductive potential at 12 weeks)

研究点 (1)

Loading locations...

相似试验